Neion

Autonomy

Investment:
Seed
Year:
2024
Location:
New York
Founders:
Demetrios Kellari, Sam Levin

Neion Bio uses genetic engineering to produce medicines in chicken eggs instead of massive industrial factories, dramatically lowering the cost of drug manufacturing.                                                                                                                

Their platform turns eggs into efficient, self-contained drug factories capable of producing therapeutic proteins at a fraction of traditional costs. As drug shortages rise and manufacturing bottlenecks persist, Neion offers a faster, cheaper, and more resilient way to make life-saving medicines in America.